News and Analysis

Triumvira Immunologics nabs $55m Series A

Austin, Texas-based Triumvira Immunologics Inc, a biopharmaceutical company, has raised $55 million in Series A financing.

-

Austin, Texas-based Triumvira Immunologics Inc, a biopharmaceutical company, has raised $55 million in Series A financing. Leaps by Bayer and Northpond Ventures led the round. Triumvira also has research facilities in Hamilton, Ontario.

Source: Press Release